KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Enterprise Value (2019 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Enterprise Value for 5 consecutive years, with -$1.0 billion as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Enterprise Value rose 19.14% year-over-year to -$1.0 billion, compared with a TTM value of -$1.0 billion through Sep 2023, up 19.14%, and an annual FY2022 reading of -$1.3 billion, up 11.57% over the prior year.
  • Enterprise Value was -$1.0 billion for Q3 2023 at Ginkgo Bioworks Holdings, up from -$1.1 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$235.9 million in Q2 2021 and bottomed at -$1.7 billion in Q3 2021.
  • Average Enterprise Value over 5 years is -$989.7 million, with a median of -$1.2 billion recorded in 2023.
  • The sharpest move saw Enterprise Value grew 24.87% in 2020, then plummeted 470.4% in 2022.
  • Year by year, Enterprise Value stood at -$495.3 million in 2019, then increased by 24.87% to -$372.1 million in 2020, then crashed by 299.86% to -$1.5 billion in 2021, then grew by 11.57% to -$1.3 billion in 2022, then increased by 20.26% to -$1.0 billion in 2023.
  • Business Quant data shows Enterprise Value for DNA at -$1.0 billion in Q3 2023, -$1.1 billion in Q2 2023, and -$1.2 billion in Q1 2023.